You will be redirected to our submission process. Vaccine research has increasingly focused on virus-like particles (VLPs) due to their unique ability to mimic the structures of viruses without ...

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a ...

Intech Investment Management LLC acquired a new stake in shares of HilleVax, Inc. (NASDAQ:HLVX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with ...

Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.

Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 West Campbell Road, Richardson, Texas 75080, United States ...

BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...

The global animal vaccines market size was US$ 8.5 billion in 2021. The global animal vaccines market is forecast to grow to US$ 13.3 billion by 2030 by growing at a compound annual growth rate (CAGR) ...